Selecta Biosciences, Inc.

Selecta Biosciences, Inc.verified

SELB

Price:

$0.8812

Market Cap:

$135.20M

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to the research and development of innovative nanoparticle immunomodulatory medications aimed at treating and preventing various human ailments. The company's most advanced gene therapy initiative is SEL-302, currently in preclinical development to enhance therapeutic options for methylmalonic acidemia. Among its biologic therapies, SEL-212 is undergoing Phase III clinical trials for the management of chronic refractory gout. Selecta is also advancing potential treatments for a range of IgA-mediated conditions, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. T...[Read more]

Industry

Biotechnology

IPO Date

2016-06-22

Stock Exchange

NASDAQ

Ticker

SELB

The PE Ratio as of June 2026 (TTM) for Selecta Biosciences, Inc. (SELB) is -3.04

According to Selecta Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.04. This represents a change of 132.82% compared to the average of -0.00 of the last 4 quarters.

Selecta Biosciences, Inc. (SELB) Historical PE Ratio (quarterly & annually)

How has SELB PE Ratio performed in the past?

The mean historical PE Ratio of Selecta Biosciences, Inc. over the last ten years is -3.09. The current -3.04 PE Ratio has changed 9.73% with respect to the historical average. Over the past ten years (40 quarters), SELB's PE Ratio was at its highest in in the June 2021 quarter at 25.99. The PE Ratio was at its lowest in in the June 2016 quarter at -8.85.

Quarterly (TTM)
Annual

Average

-3.09

Median

-1.68

Minimum

-14.51

Maximum

4.62

Selecta Biosciences, Inc. (SELB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Selecta Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 230.22%

Maximum Annual PE Ratio = 4.62

Minimum Annual Increase = -131.87%

Minimum Annual PE Ratio = -14.51

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.13-90.05%
2024-1.34184.05%
2023-0.47-110.18%
20224.62-131.87%
2021-14.51230.22%
2020-4.39117.00%
2019-2.02122.14%
2018-0.91-70.28%
2017-3.07-64.74%
2016-8.7021.57%

Selecta Biosciences, Inc. (SELB) Average PE Ratio

How has SELB PE Ratio performed in the past?

The current PE Ratio of Selecta Biosciences, Inc. (SELB) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.65

5-year avg

-2.37

10-year avg

-3.09

Selecta Biosciences, Inc. (SELB) PE Ratio vs. Peers

How is SELB’s PE Ratio compared to its peers?

Selecta Biosciences, Inc.’s PE Ratio is less than Pardes Biosciences, Inc. (-1.36), less than aTyr Pharma, Inc. (-0.62), less than Paratek Pharmaceuticals, Inc. (-1.91), less than NGM Biopharmaceuticals, Inc. (-0.89), less than Decibel Therapeutics, Inc. (-1.95), less than Sesen Bio, Inc. (0.84), less than Kinnate Biopharma Inc. (-1.10), less than Cyteir Therapeutics, Inc. (-2.42), greater than F-star Therapeutics, Inc. (-3.79), less than Opiant Pharmaceuticals, Inc. (30.58),

Build a custom stock screener for Selecta Biosciences, Inc. (SELB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Selecta Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Selecta Biosciences, Inc. (SELB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Selecta Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Selecta Biosciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Selecta Biosciences, Inc. (SELB)?

What is the highest PE Ratio for Selecta Biosciences, Inc. (SELB)?

What is the 3-year average PE Ratio for Selecta Biosciences, Inc. (SELB)?

What is the 5-year average PE Ratio for Selecta Biosciences, Inc. (SELB)?

How does the current PE Ratio for Selecta Biosciences, Inc. (SELB) compare to its historical average?